Meridian Wealth Management LLC Boosts Stock Position in DaVita Inc. (NYSE:DVA)

Meridian Wealth Management LLC grew its stake in shares of DaVita Inc. (NYSE:DVA) by 14.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,341 shares of the company’s stock after acquiring an additional 1,073 shares during the period. Meridian Wealth Management LLC’s holdings in DaVita were worth $1,367,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Bessemer Group Inc. lifted its position in shares of DaVita by 2,335.6% during the first quarter. Bessemer Group Inc. now owns 10,741 shares of the company’s stock worth $1,483,000 after acquiring an additional 10,300 shares in the last quarter. BOKF NA raised its position in shares of DaVita by 286,550.0% in the first quarter. BOKF NA now owns 5,733 shares of the company’s stock worth $790,000 after buying an additional 5,731 shares in the last quarter. Assenagon Asset Management S.A. raised its position in shares of DaVita by 29.6% in the second quarter. Assenagon Asset Management S.A. now owns 50,096 shares of the company’s stock worth $6,942,000 after buying an additional 11,454 shares in the last quarter. Comerica Bank raised its position in shares of DaVita by 41.4% in the first quarter. Comerica Bank now owns 34,431 shares of the company’s stock worth $4,753,000 after buying an additional 10,074 shares in the last quarter. Finally, MBB Public Markets I LLC purchased a new stake in shares of DaVita in the second quarter worth $582,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Insider Activity

In other news, CEO Javier Rodriguez sold 32,176 shares of the firm’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $155.93, for a total transaction of $5,017,203.68. Following the transaction, the chief executive officer now directly owns 905,659 shares of the company’s stock, valued at approximately $141,219,407.87. This trade represents a 3.43 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Joel Ackerman sold 64,029 shares of the firm’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $155.06, for a total value of $9,928,336.74. Following the completion of the sale, the chief financial officer now directly owns 111,481 shares in the company, valued at $17,286,243.86. The trade was a 36.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 156,086 shares of company stock valued at $24,807,161. 2.00% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on DVA shares. UBS Group increased their price objective on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Truist Financial increased their target price on DaVita from $165.00 to $175.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Barclays increased their target price on DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. Finally, Bank of America increased their target price on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a research note on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, DaVita currently has an average rating of “Hold” and a consensus price target of $161.80.

DaVita Stock Up 0.8 %

DVA opened at $165.51 on Friday. The business’s fifty day simple moving average is $158.31 and its 200 day simple moving average is $148.29. DaVita Inc. has a 52 week low of $98.26 and a 52 week high of $168.50. The stock has a market cap of $13.57 billion, a PE ratio of 17.85, a P/E/G ratio of 0.93 and a beta of 0.89. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The company had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period last year, the business posted $2.85 earnings per share. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. As a group, research analysts expect that DaVita Inc. will post 9.71 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.